Insights from response to tyrosine kinase inhibitor therapy in a rare myeloproliferative neoplasm with CALR mutation and BCR-ABL1

Research output: Contribution to journalLetterpeer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Insights from response to tyrosine kinase inhibitor therapy in a rare myeloproliferative neoplasm with CALR mutation and BCR-ABL1'. Together they form a unique fingerprint.